Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432,001,939
-
Total 13F shares
-
298,186,963
-
Share change
-
+6,605,695
-
Total reported value
-
$11,983,269,244
-
Put/Call ratio
-
7.9%
-
Price per share
-
$40.18
-
Number of holders
-
311
-
Value change
-
+$263,400,168
-
Number of buys
-
175
-
Number of sells
-
109
Institutional Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q3 2022
As of 30 Sep 2022 Royalty Pharma plc - Common Stock (RPRX) had 311 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 298,186,963 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, VIKING GLOBAL INVESTORS LP, JPMORGAN CHASE & CO, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, and SIGULER GUFF ADVISERS, LLC.
This table shows 311 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.